4-(3,4-DICHLORO-PHENYL)-THIAZOL-2-YLAMINE CAS:39893-80-6
Catalog Number | XD95885 |
Product Name | 4-(3,4-DICHLORO-PHENYL)-THIAZOL-2-YLAMINE |
CAS | 39893-80-6 |
Molecular Formula | C9H6Cl2N2S |
Molecular Weight | 245.13 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
4-(3,4-Dichloro-phenyl)-thiazol-2-ylamine is a compound that belongs to the thiazole family. It contains a thiazole ring with a 3,4-dichloro-phenyl group attached to it. The specific chemical structure of this compound influences its properties and potential effects.One of the notable characteristics of 4-(3,4-Dichloro-phenyl)-thiazol-2-ylamine is its potential as a bioactive compound. Thiazole derivatives have been extensively studied for their pharmaceutical properties, including antimicrobial, anticancer, anticonvulsant, and anti-inflammatory activities. The 3,4-dichloro-phenyl group present in this compound can further enhance its biological effects. Research has shown that thiazole derivatives exhibit antimicrobial activity against various pathogens, making them potential candidates for the development of new antibiotics. In addition, they have demonstrated anticancer properties by inhibiting the growth of cancer cells and inducing cell death. The 3,4-dichloro-phenyl group may contribute to these properties by enhancing the compound's interaction with cellular targets.Furthermore, the presence of the thiazole ring in 4-(3,4-Dichloro-phenyl)-thiazol-2-ylamine confers unique chemical and structural characteristics. Thiazole derivatives have shown potential as enzyme inhibitors, particularly for enzymes involved in diseases such as HIV, diabetes, and Alzheimer's. This suggests that this compound could be explored for its potential as a therapeutic agent targeting specific enzymes involved in these diseases.Moreover, thiazoles have also demonstrated anti-inflammatory effects by inhibiting the production of inflammatory mediators. This property is of interest for the development of drugs to treat inflammatory conditions such as rheumatoid arthritis and inflammatory bowel disease. The 3,4-dichloro-phenyl group present in this compound may contribute to its anti-inflammatory activity by modulating specific inflammatory pathways or targets.In summary, 4-(3,4-Dichloro-phenyl)-thiazol-2-ylamine possesses potential biological activities that make it a subject of interest in pharmaceutical research. Its antimicrobial, anticancer, and anti-inflammatory properties indicate its potential as a broad-spectrum therapeutic agent. Further studies and exploration of this compound may provide valuable insights for the development of new drugs targeting various diseases.